Skip to main content

Table 1 Relationship between lncRNA uc.134 expression and the clinical characteristics of HCC patients

From: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1

lncRNA uc.134 expression

Features

n

Low

High

x 2

P value

All cases

170

121

49

  

Age

   

0.169

0.412

 <50

56

41

15

  

 ≥50

114

80

34

  

Gender

   

0.332

0.377

 Man

145

102

43

  

 Female

25

19

6

  

Histological grade

   

2.488

0.288

 Well

13

8

5

  

 Moderately

79

53

26

  

 Poorly

78

60

18

  

HBsAg status

   

0.001

0.566

 Negative

48

34

14

  

 Positive

119

84

35

  

Serum AFP (ng/ml)

   

3.885

0.037

 <25

67

42

25

  

 ≥25

103

79

24

  

Tumor size (cm)

   

0.042

0.487

 <5

113

81

32

  

 ≥5

57

40

17

  

Tumor number

   

4.044

0.032

 Single

145

99

46

  

 Multiple

25

22

3

  

Lymph node metastasis

   

6.851

0.005

 Negative

139

93

46

  

 Positive

26

24

2

  

TNM stage

   

51.393

0.000

 I and II

67

27

40

  

 III and IV

103

94

9

  
  1. P value <0.05 was considered to indicate statistical significance. The P values were calculated in SPSS 17.0 using Pearson’s chi-square test
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us